Prevalence of Factor V Leiden and G6PD 1311 silent mutations in Dalmatian population

被引:12
作者
Cikes, V
Abaza, I
Krzelj, V
Terzic, IM
Tafra, R
Trlaja, A
Marusic, E
Terzic, J
机构
[1] Univ Split, Sch Med, Mol Biol Lab, Split 21000, Croatia
[2] Univ Hosp Split, Dept Paediat, Split, Croatia
[3] Univ Hosp Split, Dept Transfus Med, Split, Croatia
关键词
Factor V Leiden; G6PD; silent mutation 1311; Dalmatia;
D O I
10.1016/j.arcmed.2004.07.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Factor V Leiden has been described as a common genetic risk factor for venous thromboembolism. The geographic distribution of this abnormality varies greatly, being high in Europe and almost absent in Asia and Africa. Particularly high prevalence is observed in some Mediterranean countries, which suggests the Mediterranean origin of this mutation. Similarly, prevalence of silent mutation 1311 of the G6PD gene seems to be higher among Mediterranean populations. Since the Dalmatian population (of south Croatia) geographically belongs to the Mediterranean populations we analyzed the prevalence of FV-Leiden and silent mutation 1311 in this region. Furthermore, because the coincidence of G6PD deficiency and venous thromboembolism was described earlier, we tested a possible association of FV-Leiden and G6PD deficiency. Methods. One hundred sixty-eight healthy blood donors and 55 G6PD deficient individuals originating from the Dalmatian region were tested for the presence of FV-Leiden mutation and silent mutation 1311. Results. Prevalence of FV-Leiden among blood donors was 2.4%, while among G6PD deficient individuals it was significantly higher, 11% (p = 0.011). Prevalence of silent mutation 1311 among blood donors and G6PD deficient individuals was 21 and 15%, respectively. Conclusions. Observed allele frequencies among individuals originating from the Dalmatian region is similar to the neighboring European and Mediterranean populations. Interestingly, our results indicate the association of the FV-Leiden and G6PD deficiency and warrant further studies. (C) 2004 IMSS. Published by Elsevier Inc.
引用
收藏
页码:546 / 548
页数:3
相关论文
共 20 条
  • [1] BEUTLER E, 1990, AM J HUM GENET, V47, P1008
  • [2] The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels
    Cattaneo, M
    Chantarangkul, V
    Taioli, E
    Santos, JH
    Tagliabue, L
    [J]. THROMBOSIS RESEARCH, 1999, 93 (01) : 1 - 8
  • [3] Cittadella B, 1997, ANN HUM GENET, V61, P229
  • [4] Ioannou HV, 2000, INT ANGIOL, V19, P314
  • [5] JABLONSKASKWIECINS, 1997, EUR J HUM GENET, V5, P22
  • [7] KIRKWOOD BR, 1991, ESSENTIALS MED STAT, P183
  • [8] VENOUS THROMBOSIS DUE TO POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - LEIDEN THROMBOPHILIA STUDY
    KOSTER, T
    ROSENDAAL, FR
    DERONDE, H
    BRIET, E
    VANDENBROUCKE, JP
    BERTINA, RM
    [J]. LANCET, 1993, 342 (8886-7) : 1503 - 1506
  • [9] Prevalence of G-6-PD deficiency in the Croatian Adriatic coast population
    Krzelj, V
    Zlodre, S
    Terzic, J
    Mestrovic, M
    Jaksic, J
    Pavlov, N
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2001, 32 (05) : 454 - 457
  • [10] Population genetics of factor V Leiden in Europe
    Lucotte, G
    Mercier, G
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (02) : 362 - 367